The following is part of a growing body of evidence that anyone taking cholesterol lowering drugs (statins) should
be supplementing their diet with a quality
Coenzyme Q10 product (especially those experiencing muscular
pain!!!).  Please call for details. 828.296.0000!!!


American College of Cardiology 54th Annual Scientific Session.        Related Articles, Links

Coenzyme Q10 Lessens Muscle-Related Side Effects in Patients on Statins
Division of Cardiology, State University of New York at Stony Brook, New York 11790, USA.
tstys@aol.com
Kelly, P.

ORLANDO, FL -- March 7, 2005 -- Patients with significant myopathy who are taking statin therapy have a
significant decrease in myopathic pain after 30 days of supplementation with coenzyme Q10, according to
results presented here on March 6th at the American College of Cardiology 54th Annual Scientific Session.

Patricia Kelly, DO, Associate Professor of Medicine, University Hospital Medial Center, Stony Brook, New York,
United States, randomized in a double-blind design 41 statin-treated patients with myopathic pain to 30 days of
supplementation with 400 IU of vitamin E or 100 mg daily of coenzyme Q10.

"Statin treatment markedly reduces [the incidence of] cardiac events and mortality," Dr. Kelly said. "However, the
reported side effects of treatment include myopathy, muscle damage associated with increased levels of
creatinine phosphokinase, and abnormalities of liver function."

The researchers conducted the present trial to determine if coenzyme Q10 supplementation would improve
muscle related adverse effects in patients on statins. "If coenzyme Q10 supplementation were effective in
reducing the symptoms of myopathy associated with statin use, it would be possible for patients to retain the
beneficial effects of cholesterol lowering while reducing significant side effects," she added.

The two treatment groups were similar with respect to demographic and clinical parameters.

Pre- and post- vitamin E, pain remained unchanged (3.9 versus 4.4, P = NS). Pre- and post coenzyme Q10, pain
improved significantly (6.2 1.7 versus 3.1, P <.001).

Pain improved in three of 20 vitamin E patients and 18 of 21 coenzyme Q 10 patients (P <.001).

There was no significant change in creatinine phosphokinase with treatment in either group nor did these levels
correlate with pain severity.

Coenzyme Q10 did not have any effect on lipid levels and was safe and well tolerated.

"This study provides encouraging evidence for the use of
coenzymeQ10 in alleviating myopathic pain in
patients taking statins," Dr. Kelly said.

Study strengths include the 100% compliance rates, randomized blinded design, use of validated pain scale, and
duration of treatment of 4 weeks to ensure adequate absorption of coenzyme Q10, she added.